10 May, 2019
Interviews on “The global research on therapeutic approaches for pediatric HIV infection”
Lynne M. Mofenson is a key member of the Independent Scientific Advisory Board, and provides external consultancy for EPIICAL. She is a pediatric infectious disease specialist who has spent her…
14 Mar, 2019
CROI 2019: Oral presentation by members of the EPIICAL team
The annual Conference on Retroviruses and Opportunistic Infections (CROI) was held on 4-7 March 2019, at the Washington State Convention Center in Seattle, Washington.
01 Mar, 2019
CROI: Members of the EPIICAL team to attend in Seattle
Seattle is gearing up for the 2019 edition of CROI next week. Held at Washington State Convention Center on 4th-7th March, the Conference on Retroviruses and Opportunistic Infections is an important event…
22 Nov, 2018
A paper on predictors of faster virological suppression in HIV infected children has been just accepted for publication in AIDS
Born from the collaboration among EPPICC and EPIICAL, the paper “Predictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand” demonstrates that even amongst HIV infected…
20 Nov, 2018
The EPIICAL 2nd General Assembly was a fabulous success!
Held at the Hospital General Universitario Gregorio Marañón on 14th to 16th November 2018, the 2nd EPIICAL General Assembly welcomed around 50 scientists and healthcare professionals working together to establish…
13 Nov, 2018
2nd EPIICAL General Assembly meeting, 14-16 November 2018, Madrid
Madrid will play host to the 2nd EPIICAL General Assembly meeting from November 14th to 16th 2018. We look forward to welcoming our project partners from 26 organisations across 4…
05 Oct, 2018
CARMA: enrolment has completed!
September saw the CARMA study complete its enrolment target of 40 patients.
02 Jul, 2018
Early and highly suppressive ART are main factors associated with low viral reservoir in European perinatally HIV infected children
An EPIICAL paper has been accepted for publication in the Journal of Acquired Immune Deficiency Syndromes (JAIDS)